Here's a short patient friendly article that again shows that PSMA-PET scans help patients make better treatment decisions. And, Ira and I will say it again. The bone scan is history. Insist on a PSMA-PET scan. 

November 29, 2025​

AI integration in healthcare is outpacing legal frameworks, creating liability challenges for physicians, health systems, and manufacturers.

· The standard of care may evolve to include AI, affecting what is considered "reasonable" practice in medicine.

November 22, 2025​

Dutch researcher Professor Monique Roobal, Ph. D. MSc. with the Erasmus Medical Centre in Rotterdam, shares news that’s encouraging yet not surprising. Routine Prostate Stimulating Antigen testing saves lives.

November 15, 2025​

Investigate various Advantage plans MEDICAL NEWS TODAY says are among the best. 

November 8, 2025​

Disease free survival. The goal every cancer patient wants to hear is elusive. A recent clinical trial may get us to disease-free survival with newly diagnosed patients with moderate to high-risk disease still in the gland.

November 1, 2025​

Radiation has been made safer with the development of a genetic test called PROSTOX that in early trials looks like it can predict who will suffer late-stage side effects and who is likely good to go with MRI guided or PSMA guided SBRT and spacing methods to protect the rectum.

October 25, 2025​

Prostate cancer is the only malignancy diagnosed by random biopsy and MRI guidance makes
biopsies accurate. Multiparametric magnetic resonance imaging is the standard for detecting prostate cancer.

Sept 27, 2025​

We’ve all been waiting for a prostate cancer detection method with better accuracy than prostate specific antigen (PSA). Theis article describes research at Johns Hopkins into a urine test that can detect prostate cancer biomarkers

Sept 20, 2025​

Here's a patient friendly article discussing how micro-ultrasound will someday soon improve the ability to find cancer in the gland thus making more correct biopsies. Add the benefits of costing hospitals and doctors less than the purchase of an MRI machine and getting patients to diagnose faster and more often because they don’t have to join an extensive line for MRI appointments and we get real benefits from this innovative technology.

Sept. 13, 2025​

The purpose of the Saturday post is to educate our men and their families about prostate cancer. What better experience than to have our fearless leader recount his experience with one of the much talked about whole gland and focal HIFU therapy. Let's hear it from Neal
Berke for this interesting real-world account of HIFU.

August 30, 2025​

Uro-Today sent me links to several patient friendly videos and articles concerning PSMA-PET CT scans. Simply, PSMA-PET CT scans can advance diagnostic accuracy and precision treatment towards lowering mortality, morbidity, treatment side effects and perhaps treatment hassle and cost.

August 23, 2025​

This is an encouraging, patient-friendly article about a 30-year study of survival and prostate cancer patients.

August 16, 2025​

Here’s the link to a patient friendly and exciting article and video discussing some of the past, present and future of High Intensity Focused Ultrasound ablation, the role HIFU plays in active surveillance, and Focal One Robotic HIFU.

August 9, 2025​

How about some news about a new theragnostic agent that looks like it will be a promising weapon against metastatic castration resistant prostate cancer? The first in vivo clinical trial of terbium-161 produced few side effects and a good result towards reducing both metastatic cells and micro-metastatic single cells thus outperforming Lutetium 177.

August 2, 2025​

One of our group members wanted to know about theranostic treatment without chemotherapy. Dr. Finkelstein was the first to use Pluvicto without chemotherapy. This is an interesting discussion of the recent interest and excitement in theranostic medicine.

July 26, 2025

​

Medical News Today hits a triple home run with this vital piece by Faye Steward. Read it, share it with your friends and family. Steward has answers to questions we all ask about Medicare if we even know we need to ask these questions.

July 19, 2025

​

I knew you were busy with out-of-town guests and vacations this weekend. How about a short,
patient friendly article that could help you understand Part C?

July 12, 2025

​

Here’s a new germline (genetics) test developed by MiraDx and our presenter Joanne B.
Weidhaas, M.D 

July 5, 2025

​

 A professionally written, straightforward piece about Medicare changes. You may want to bookmark it for future reference and check it against your own eligibility.

June 28, 2025

​

A patient friendly article about Pluvicto for the treatment of some forms of metastatic castration resistant prostate cancer. Good news: Increased progression free survival. Now the theranostics can be used before the chemotherapy. Hopefully this will avoid some of the exposure to the side effects of the Taxene chemotherapy.

June 21, 2025

​

This month I found an article about Proscar and side effects that was surprising. I practiced for 30 years plus and never have my patient’s reported depression, suicidal thoughts, anxiety or any other psychological consequence from the use of Proscar or similar medications.

June 14, 2025

​

Micro ultrasound (MUS) diagnostic technology emerges and takes a step forward with the above multinational study showing it’s “non-inferior” to conventional MRI.

June 07, 2025

​

Professor Samir Taneja, M.D of New York University’s Langone Health Center’s Urology,
Oncology and Radiology Departments presented on several issues concerning focal therapies in the United States.

May 24, 2025

​

 Black men are at greater risk for serious prostate cancer and at greater risk for discovering it later and experiencing it earlier in their lives. That’s consensus among prostate cancer researchers and practitioners.

May 17, 2025

​

I found a ten yearlong study of 2455 men with cancer in the prostate only that underwent

surgery or external beam radiation treatment or active surveillance in 2011 to 2012 here in the USA. The research team wanted to know about side effects of treatment (or maybe no treatment in active surveillance) and compare post treatment risks side by side. Here's what they found.

May 3, 2025

​

 I want to share a short, patient friendly article that you will find important, especially if you are over 70 years old or so. If you’ve regularly attended our Support & Information groups, you’ve heard fellow prostate cancer patients discuss how their treatments are affected by other medical conditions. Good medicine strives to cure or reduce the impact of ailments without creating bigger problems. “First, do no harm."

April 26, 2025

​

Medical history is full of obsolete treatments and some never worked. Next in line for the history books is using a bone scan to find prostate cancer in the skeleton according to Professor Daniel Spratt, M.D. a radiation oncologist with Case Western Reserve University Comprehensive Cancer Center in Cleveland, Ohio.

April 12, 2025

​

Let’s look at two pharmaceutical firms whose products may provide precision cancer therapy soon. There are two reasons we are looking in the neighbor’s yard tonight. Frist, variations of these drugs may someday fight prostate cancer. And many of us know someone close to us fighting blood or breast or other cancers and they are looking for answers beyond what has been presented

April 5, 2025

​

Researchers wanted to know the effect of adding ADT’s to SBRT to treat oligometastatic disease. They found their patients receiving two therapies at once delays Mets for more than twice as long as the group treated with SBRT only.

March 29, 2025

​

How does robotic HIFU stack up against radical prostatectomy? According to Pascal Rischmann,
MD, PhD, a urologist and president of the Surgical Society of France, HIFU is at worst
“noninferior” and at best superior to surgery as far as its ability to kill intermediate risk cancer in
the gland without long term side effects of impotence, urinary leakage and damage to the
rectum and other tissues surrounding the prostate.

March 22, 2025

​

A study at the Juravinski Cancer Centre in Canada indicated that patients with a simultaneous high dose brachytherapy with external beam radiation had a high enough rate of progression free survival and low enough rate of toxicity to make this treatment the new standard of care at the Centre.

March 15, 2025

​

Ira and I are keen on second opinions for prostate cancer biopsies. We are considering advocating second opinions on MRI’s as well. Pathology and radiology are the same as other skilled fields. Some know more than others and are better at picking up subtle differences. That difference in skill might make a huge difference in the quality of treatment you get. Here's a link to a simple and straightforward article. 

March 8, 2025

What if a take-home urine test could quickly and inexpensively eliminate the need for prostate
biopsies in men with indolent cancer? The accuracy of the My Prostate Score test was validated once again in a clinical study of men with known grade cancers. This test detects biomarkers for serious cancers like the PROMISE saliva test we’ve been urging our support group members to take.

February 22,2025

Dr. G . Chiarelli and his team assessed mortality associated with active surveillance. They examined the medical records of 546 men, 75 years and younger who were diagnosed between 1995 and 2022. They decided on a criterion for compliance with active surveillance guidelines.

February 8,2025

A study led by Dr. Amar Kishan of UCLA, a recent presenter to the Forum, found that MRI guided SBRT does in fact protect healthy tissues outside of the margins. Those treated with MRI radiation did significantly better with bladder and bowel toxicity and sexual function than with CT.

January 25,2025

Here’s some potentially good news for those of us who want to spend less time in an MRI machine, cut MRI costs, or are concerned about contrast media side effects.

January 18,2025

We discuss genetic testing’s value in creating a personalized treatment plan resulting in metastasis - free survival without additional side effects and costs. The above article discusses the value of using androgen deprivation therapy (hormone therapy) with an androgen receptor inhibitor. Let’sunderstand how Metastatic P Ca grows.

January 11,2025

A controlled study involving 13,000 Swedish men aged 50-60 shows that MRI use REDUCES THE NEED FOR BIOPSIES OF CLINICALLY INSIGNIFICANT (Gleason 3 + 3) CANCERS.

December 14, 2024

Recent City of Hope research on mice demonstrated that white button mushroom extract increased the number of T cells and natural killer cells in mice infected with prostate cancer tumor components and reduced the tumor’s ability to fight off T Cells. 

​

Professor Cary Presant, MD presented updates to the Forum in a Guest Chat in June 2023.

December 7, 2024

Data is now available from the PREVENT study from a research team headed by Jim C Hu, MD,
MPH, a professor of urology at Weill Cornell Medicine / New York-Presbyterian Hospital, in which the researchers want to know if trans perineal biopsies (TP) provide better cancer detection with fewer infections than traditional trans rectal biopsies (TR).

November 30, 2024

I found something exciting for our friends on the East Coast. Memorial Sloan – Kettering Centers have MRI Guided SBRT developed by a 50-year-old Swedish corporation, a worldwide
leader in oncology radiation market, called “Elekta”. 

November 16, 2024

Check out this concise, well-written article by CNN Health about next year’s Medicare Advantage changes. Some changes you may like and some not so much.

November 2, 2024

We know that the sooner we spot Mets post-surgery, the better the chances of controlling its spread. Testing is the name of the cancer treatment and recovery game. Click on the link for good news coming from a small study of men with low PSAs after surgery.

October 26, 2024

Get More Information for Better Decision Making

October 19, 2024

Dr. Metzger talks about a detection process called a Prostate Specific Membrane Agent Positron Emission Tomography. It’s something he and Ira talk about at nearly every meeting for our visitors who have high Gleason scores, high prostate stimulating antigen labs, or who may be experiencing biochemical recurrence.

October 12, 2024

Decipher is a painless, no fuss means of detecting genetic aberrations that could lead to cancer spread and treatment challenges. Researchers discovered that patients with a high Decipher genetic test score did better with docetaxel than those with a low Decipher score. 

October 5, 2024

We look at a study from across the pond that compares post operative treatment modalities
commonly used to promote metastasis free survival for prostate cancer patients.

September 21, 2024

Tonight, we examine a link between prostate cancer and virus particles that entered our collective DNA some 30 million years ago. 

September 7, 2024

Fluorine-18 prostate-specific membrane antigen (PSMA)-1007 PET/CT improves locoregional staging compared with MRI in patients undergoing surgery for intermediate and high-risk prostate cancer.

August 31, 2024

Centers for Medicare & Medicaid Services proposed rule change will cover payment for PET imaging agents for Prostate Cancer and more.

August 3, 2024

The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.

July 6, 2024

Last week I told you about Micro-Ultrasound and how it may replace MP-MRI as a diagnostic
tool. Now, another exciting development suggests the medical community will have a smaller,
more portable, more affordable MRI machine to use on a variety of diagnostic tasks once it’s
approved by the United States Food and Drug Administration.

June 8, 2024

The advantages of ultrasound (US) over MRI pushed researchers towards developing an US that can create images that are 3 to 4 times higher resolution than traditional US and at least as clear as MRI images. The result of their labor is Micro-Ultrasound (MUS). And not too far away, Artificial Intelligence enhanced Micro-Ultrasound (AIMUS). The latter will lead to more accurate and complete reading of the sound generated image.

June 1, 2024

Remarkable article about a study done on men after radical prostatectomy that had Gleason 8,9, 0r 10. The biochemical recurrence rate was zero at 24 months using mostly Erleada and Relugolix.

May 18, 2024

Metastasis Directed Therapy is used with all kinds of cancers. It can be done with surgery and /
or radiation delivered by external beam (IMRT, SBRT) or via Theranostics. Sometimes chemotherapy or hormone blockers are added. The objective is to stop cancer from spreading by either taking out what is “feeding” the cancer and / or preventing the Mets from creating more Mets. Hormone therapies have side effects that vary depending on the patient and the drug. Chemotherapy has side effects too.

May 4, 2024

New treatment option for prostate cancer shows successful outcomes. MRI Guided Transurethral Ultrasound Ablation has a high success rate without side effects associated with surgery.

April 27, 2024

Something old is new again. Years ago, men with Mets. were treated with estrogen instead of ADTs to deprive prostate cancer of testosterone. The study says patients who opted for treatment with estradiol skin patch had fewer side effects such as hot flashes, mood swings, blood pressure, blood sugar and cholesterol issues, reduced bone density and so forth than those who got ADTs.

April 20, 2024

Targeted radiation therapy via MRI guided SBRT can be an effective control of various oligometastatic cancers even without chemotherapy and / or ADTs. That’s a quick summary of some of the exciting discoveries discussed in the above article.

April13, 2024

The clinical trial scene is evolving and changing, and we are in an exciting time for such treatments. I want to share a list of contacts you can ask about clinical trials.

April 6, 2024

Click on the link in the newsletter to find out more about NEW clinical trials going on around the nation See if you qualify.

March 30, 2024

Genetic screening panels can alert patients to their potentially higher cancer risks. While they are not yet 100% reliable they can communicate the need for increased watchfulness going forward.

March 23, 2024

I wanted to share a study that correlates lower Alzheimer’s Disease risk in men with specific risk factors with the use of Viagra or Cialis. The connection between these drugs and Alzheimer’s is particularly interesting to P Ca patients as many of you are using them for ED and / or controlling urinary incontinence. Thus the question: are there unintended benefits to using these meds and if so, what dosages are needed to obtain benefits in men and maybe women with an increased risk of Azheimer’s?

March 9, 2024

Here’s a link to a quick, patient friendly video discussing research that suggests your prostate

cancer fight will be more successful with moderate exercise and good nutrition. Moderate wine intake is also good, and I am glad to hear that.

March 2, 2024

We may be as close as five years to having an injection for most if not all genetically based

diseases according to F. Perry Wilson M.D., M.S.C.E., of Yale Medical School.

November 25, 2023

I found a ten yearlong study of 2455 men with cancer in the prostate only that underwent

surgery or external beam radiation treatment or active surveillance in 2011 to 2012 here in the USA. The research team wanted to know about side effects of treatment (or maybe no treatment in active surveillance) and compare post treatment risks side by side. Here's what they found.

February 17, 2024

Black men are at greater risk for serious prostate cancer and at greater risk for discovering it later and experiencing it earlier in their lives. That’s consensus among prostate cancer researchers and practitioners.

February 10, 2024

Giving the finger to the finger?

In this study, the Digital Rectal Exam (DRE - the finger) is found to be less effective that some more recent diagnostic techniques.

February 3, 2024

Medicare/Medicaid sets pay schedule for artificial intelligence assistance to P Ca testing, and that's just a start...

January 20, 2024

While not a holiday present, assistance with medication cost is welcome this time of year and

throughout the year. I see many drug companies offering help with patient drug costs and for a wide variety of illnesses. So, ask your pharmacist or heath care provider about financial relief for the Meds you and your loved ones take.

December 16, 2023

Scanxiety is the stress you may feel around your cancer tests. There are several things that you can do to manage scanxiety.

November 4, 2023

PSMA-PET scans are more selective and more sensitive than conventional imaging. Here, four expert physicians discuss how these scans are changing the way they practice medicine, criteria for ordering PSMA-PET scans and how PSMA-PET scans can better serve patients and doctors.

October 28, 2023

Dr. Spratt, author of this article, will join us on Thursday, October 26th at 5:00 p.m. Pacific Time on zoom to address the role of artificial intelligence in treating prostate cancer.

October 7, 2023

The title says it all. OTC alternative to ED drugs will be available soon in the US.

​

Added 10/10/2023: check eroxongel.com for availability in the US.

September 30, 2023

Medicare can be a confusing business. Dr. Metzger presents an article that describes a tool that helps you choose a Part D plan that meets your needs, and follows up with some further advice for navigating Part D.

September 23, 2023

Links to a podcast and discussion of the effectiveness of flotufolastat F 18.

August 12, 2023

Report in the Orange County Register tells how top quality medical care is growing rapidly in Orange County.

July 29 2023

Tonight, we will look at the Mark Cuban Cost Plus Drug Company (“Cost Plus”) and other options for holding down drug costs. Cost Plus is a mail order pharmaceutical house that manufacturers one hundred prescription drugs. Its business model saves money and passes savings onto consumers.

July 8, 2023

Dr. Calais of UCLA reports on a study that suggests we are getting closer to real time evidence that PSMA Guided (precision) radiation is the real deal and will make treatment of early metastatic disease more accurate and ready for prime time!!

July 1, 2023

“Would a heart healthy, vegan or vegetarian diet improve my P Ca outcome?” This question gets asked a lot at our meetings. This article answers that some of the cancer or drug related side effects may be improved, but since it was not controlled for pure vegan vs vegetarian, it is still not known what a true vegan diet may do for prostate cancer patients. Heart healthy diet still remains the diet of choice since men are usually in the heart risk age when prostate cancer is diagnosed.

June 17, 2023

Tonight, Dr. Metzger shares a list of current clinical trials with you. The clinical trial scene is evolving and changing and we are in an exciting time for such treatments. He also shares a list of contacts in Orange County that you can ask about clinical trials.

June 10, 2023

Here’s strong evidence that the medical community is looking at standardizing detection and treatment modalities for low grade prostate cancer and is moving towards international consensus. This is exciting news for AS patients who hear so many different things about detection and treatment of Gleason 3+3 and low grade 3+4 P Ca.

May 27, 2023

Here’s some good news. In a promising US study, patients who got both intermittent hormone therapy and radiation saw a 75 % reduction of P Ca progression or death over their counterparts who only got intermittent hormone therapy.

May 20, 2023

The ProtecT trial was a UK-based study where 1600 men were randomized to either active monitoring, prostatectomy, or radiotherapy. The trial followed up on these men for 15 years and found that there were no significant differences in mortality between the groups.

May 13, 2023

Several United Kingdom researchers demonstrated that prostate cancer treated or not has low mortality. Keep in mind we are primarily discussing mortality.

May 6, 2023

In tonight's newsletter, Dr. Metzger looks at a study of 55,432 European men who were followed for 16 years to determine if the quantity of PSA in a first routine draw can predict the likelihood of developing a Gleason 7 or more serious cancer. The results are encouraging.

April 29, 2023

A recent Canadian study demonstrates how well a Prostate Specific Membrane Antigen called “Piflufolastat F 18” or “Pylarify” used with PET / CT scan can locate metastatic prostate cancer in post treatment patients with low PSA levels.

April 15, 2023

Summary and analysis of a study called Patient Reported Outcomes 12 Years After Localized Prostate Cancer Treatment.

April 1, 2023

Patients with prostate cancer whose diets included the highest amounts of plants had a lower risk of disease progression and recurrence, according to findings shared during the 2023 ASCO Genitourinary Cancers Symposium.

March 25, 2023

This paper discusses the results from the PACE-A trial, comparing quality of life outcomes from surgery vs stereotactic body radiotherapy (SBRT) among patients with intermediate-risk localized and low-risk prostate cancer.

March 18, 2023

Sign up for the PROMISE Registry. Help yourself. Help your family. Help other P Ca fighters.

To learn more, visit ProstateCancerPromise.org 

March 4, 2023

This non-invasive means of determining presence of high risk Prostate Cancer will become easier to get via Iso-PSA Blood Test and may eliminate the need for some biopsies.

February 16, 2023

MRI-guided SBRT reduced both acute toxicity effects and decrements in quality-of-life measures when compared with CT-guided SBRT, according to findings published in JAMA Oncology

February 4, 2023

A little change of pace. Here's the Fall 2022 UCLA Urology Newsletter featuring our Nov. presenter Professor Leonard S. Marks, M.D. and his coworkers. We hope it will help you prepare for the Nov. presentation.

October 29, 2022

Just a brief glimpse of the literature regarding MRI before a biopsy. Not all studies agree but the consensus is in favor of the pre biopsy MRI fused to the ultrasound. Standard of care, to be sure.

August 12, 2022

This is a big step toward treatment intensification for men with both oligometastatic disease as well as more advanced metastatic disease.

August 6, 2022

This keeps coming up at our meetings, Dr Fuller endorses this as does UCLA.  Makes a lot of sense to prevent rectal issues with radiation.

June 24, 2022

This is a good reminder that androgen deprivation after salvage radiotherapy is the way to go, especially if the new drug is used (relugolix). Here are two articles for review.

June 18, 2022

An example of how modern technology is helping surgeons do a better job of finding proper anatomic margins to know they have resected all of the cancerous prostate.

June 3, 2022

This is the nail in the coffin for the mri vs ultrasound debate. Not only will it get the process back into the urologist office, away from the radiologist there will be less reluctance to do guided biopsies.

May 14, 2022

Here is a current update from Johns Hopkins to their 2011 original article regarding active surveillance for prostate cancer. 

May 7, 2022

The FDA officially approved these agents which will be discussed in our next talk, on Thursday, April 24, 2022 at 7 pm. Please attend and find out how all this fits together.

April 22, 2022

An extensive review of the literature about pre treatment of advanced disease with different therapies (neoadjuvant) prior to surgery or radiation

April 9, 2022

Here are two exciting new developments for the prostate cancer world. The first is treatment for men with metastatic prostate cancer that is hormone sensitive. Really impressive results. The second is the use of LU PSMA for treatment of end stage disease and its approval for use by the FDA in castrate resistant prostate cancer.

March 26, 2022

This very informative video presentation by Dr. Eric A. Klein, MD is another example of progress in the decision about how to use PSA and who needs more testing.

https://www.urologytimes.com/view/dr-eric-klein-on-the-impressive-performance-of-isopsa-in-recent-study

March 13, 2022

This is a very interesting review of the history of PSA.  Lots of twists and turns in its life as a screening tool.  Using it wisely is really the key to its existence.

March 5, 2022

Although controversial, the trend is to treat the main tumor even if there is oligometastasis (less than five sites).

February 26, 2022

This is the near future of prostate imaging.

January 29, 2022

German hospitals are offering a 3-4 day inpatient treatment called Lutetium 177. 

January 10, 2022

The FDA has approved piflufolastat F 18 injection, a prostate-specific membrane antigen–targeted positron emission tomography imaging agent to identify suspected metastasis or recurrence of prostate cancer- it is finally official.

January 4, 2022

The Exablate system, which uses high intensity ultrasound to control locally-confined prostate cancer,  is very precise for the treatment of focal prostate cancer.

November 13, 2021

This is another step forward in the theranostics arena.

November 13, 2021

This is a succinct look at the field of immunotherapy as it relates to prostate cancer. It’s a great overview of current and future treatment options.

November 1, 2021

This article answers a question at the advance meeting of the value of pre op multi parametric MRI (this was pre PSMA work) in determining if surgery is the way to go. 

October 11, 2021

The PSMA-PET imaging agents Piflufolastat F 18 and Gallium 68 PSMA-11 are approved by the FDA for managing patients with prostate cancer

September 26, 2021

This very long article really is the answer to where MRI fits into the diagnostic scheme of elevated PSA.

September 11, 2021

It was just a matter of time before another promising agent was added to the PSMA.

Sept 3, 2021

The following articles help put to rest the value of MRI fused biopsy and compares it to the regular ultrasound guided biopsy

July 31, 2021

These articles show the amazing advances in the treatment of advanced prostate cancer.

July 17, 2021

Experts in prostate cancer discuss considerations for initiating ADT therapy after definitive treatment in patients with prostate cancer in the context of biochemical recurrence.

April 27, 2021

ORGOVYX, the drug that will eventually replace Lupron or Zoladex for the treatment of advanced prostate cancer, is now readily available. This is the only androgen deprivation therapy (ADT) medicine that is not given in the form of an injection.

April 10, 2021

The use of MRI guided transurethral approach to just treat a solitary lesion is now gaining traction as a way to do a more directed minimally invasive treatment.

April 3, 2021

A really good review of the use of active surveillance in all age groups. Emphasis on clinical guidelines and non-medical factors, like Vitamin D, low-dose statin, and frequent biomarkers for disease status.

March 18, 2021

Scientists are making great strides when it comes to the gene editing technique known as CRISPR. Scientists are confident that the treatment and prevention of prostate cancer using CRISPR technique holds tremendous potential.

March11, 2021

Scientists are making great strides when it comes to the gene editing technique known as CRISPR. Scientists are confident that the treatment and prevention of prostate cancer using CRISPR technique holds tremendous potential.

February 25, 2021

The incidence of prostate cancers that have spread to the bone at diagnosis has increased since the PSA test was taken off the guidelines of the U.S. Preventative Services Task Force (USPSTF). Some modification of this recommendation needs to be considered on a case-by-case basis.

February 25, 2021

A shorter course of stereotatic body radiotherapy (SBRT) has been shown to be effective in high-risk prostate cancer. The toxicity has been favorable and the cost is competitive.

February 16, 2021